Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability
Clinical Pharmacology & Therapeutics · 2025
DOI: 10.1002/cpt.3579 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, 2025. Verfasst von Sarah K Emond und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical and Economic Review, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Health Services Accessibility, Evidence-Based Medicine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Conducting high‐quality health technology assessments requires high‐quality evidence. With evolving regulatory standards for faster approval of new pharmaceutical products, health technology practitioners often find that the evidence base available to inform their work is lacking. This review article provides case examples of how health technology assessors have grappled with this tension, from the United States and European perspective, including experiences with new therapies for large populations, such as Alzheimer's disease, and gene therapies for ultra‐rare conditions. The article concludes by offering some potential policy solutions that can meet the goals of robust evidence generation, patient access, and system affordability, including reimbursement with evidence development, outcomes‐based contracts, and other types of managed entry agreements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute for Clinical and Economic Review, Boston, Massachusetts, USA.
- Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.
- National Health Care Institute, Diemen, The Netherlands.
- Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts, USA.
ORCID-Profile: Daniel A Ollendorf
Zitieren
APA
Emond, S. K., Goettsch, W. G., & Ollendorf, D. A. (2025). Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3579
Vancouver
Emond SK, Goettsch WG, Ollendorf DA. Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.3579
BibTeX
@article{Emond2025,
author = {Emond, Sarah K and Goettsch, Wim G and Ollendorf, Daniel A},
title = {Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability},
journal = {Clinical Pharmacology & Therapeutics},
year = {2025},
doi = {10.1002/cpt.3579}
}
EUVIMED